يرجى استخدام متصفح الكمبيوتر الشخصي للوصول إلى التسجيل - تداول السعودية
حسنًا
Guggenheim Maintains Buy on Tarsus Pharmaceuticals, Raises Price Target to $84
Tarsus Pharmaceuticals, Inc. +4.24%
Tarsus Pharmaceuticals, Inc. TARS | 64.62 | +4.24% |
Guggenheim analyst Eddie Hickman maintains Tarsus Pharmaceuticals (NASDAQ:
TARS) with a Buy and raises the price target from $78 to $84.
